Soleus Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Buy	276,312 +76,312	+38%	+$106K	0.01%	93
2025 Q4	$366K	Sell	200,000 -1,294,420	-87%	-$2.6M	0.02%	89
2025 Q3	$3.56M	Hold	1,494,420	–	–	0.19%	65
2025 Q2	$8.29M	Hold	1,494,420	–	–	0.57%	43
2025 Q1	$6.43M	Hold	1,494,420	–	–	0.5%	47
2024 Q4	$32M	Buy	1,494,420 +150,755	+11%	+$3.14M	2.42%	16
2024 Q3	$25.3M	Buy	1,343,665 +67,475	+5%	+$1.34M	2.1%	16
2024 Q2	$29M	Buy	1,276,190 +89,094	+8%	+$2.14M	2.55%	10
2024 Q1	$34.9M	Buy	1,187,096 +199,998	+20%	+$3.55M	3.06%	8
2023 Q4	$7.79M	Buy	987,098 +157,000	+19%	+$1.05M	0.86%	37
2023 Q3	$5.81M	Buy	830,098 +52,500	+7%	+$641K	0.59%	48
2023 Q2	$10.7M	Buy	777,598 +32,100	+4%	+$477K	1.18%	25
2023 Q1	$13.5M	Buy	+745,498	New	+$13.8M	1.67%	22